Cycloserine, D- en es it fr

Cycloserine, D- Brand names, Cycloserine, D- Analogs

Cycloserine, D- Brand Names Mixture

  • No information avaliable

Cycloserine, D- Chemical_Formula

C3H6N2O2

Cycloserine, D- RX_link

No information avaliable

Cycloserine, D- fda sheet

Cycloserine, D- msds (material safety sheet)

Cycloserine,_D- MSDS

Cycloserine, D- Synthesis Reference

No information avaliable

Cycloserine, D- Molecular Weight

102.092 g/mol

Cycloserine, D- Melting Point

147 oC

Cycloserine, D- H2O Solubility

Soluble

Cycloserine, D- State

Solid

Cycloserine, D- LogP

-1.631

Cycloserine, D- Dosage Forms

Capsules (red and gray capsules, oral, 250mg)

Cycloserine, D- Indication

Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).

Cycloserine, D- Pharmacology

Cycloserine, a broad-spectrum antibiotic, may be bactericidal or bacteriostatic, depending on its concentration at the site of infection and the susceptibility of the organism. Cycloserine works by blocking the formation of these peptidoglycans. By doing this the walls of the bacteria become weak and it results in the death of the bacteria

Cycloserine, D- Absorption

Rapidly and almost completely absorbed (70 to 90%) from the gastrointestinal tract following oral administration.

Cycloserine, D- side effects and Toxicity

Oral LD50 in mouse is 5290 mg/kg, and in rat is over 5000 mg/kg. Symptoms of a cycloserine overdose include drowsiness, confusion, headache, dizziness, irritability, numbness and tingling, difficulty speaking, paralysis, abnormal behavior, seizures, and unconsciousness.

Cycloserine, D- Patient Information

Cycloserine, D- Organisms Affected

Enteric bacteria and other eubacteria